Agilent Survey of Pharma Lab Leaders Uncovers Challenges in Workflow and Laboratory Efficiencies
June 04 2019 - 08:00AM
Business Wire
Agilent Technologies Inc. (NYSE: A) announced today the results
of its first Pharma Lab Leaders Survey looking to gather insights
from pharmaceutical, biopharmaceutical, and contract research
laboratories in seven countries around the world.
Respondents included 650 laboratory managers, directors, and
supervisors from China, Germany, India, South Korea, Switzerland,
Austria, and the United States. The laboratories surveyed are
involved in a range of activities from disease research to
manufacturing; The market research firm Frost & Sullivan
conducted the survey on Agilent’s behalf.
“We were extremely pleased that Agilent wanted to work with us
again to explore the challenges and opportunities within this
unique group of laboratories,” said Paljit Sohal, principal
consultant, of Frost & Sullivan. “It is important for companies
like Agilent to take the time to understand their customers’
challenges as these insights can be vital, informing strategies
moving forwards.”
Respondents highlighted their unique industry challenges,
laboratory pain points, as well as goals for the future. Overall,
the primary focus was on achieving quicker results (55%), superior
quality (44%), and data integrity (43%). Over half of the
respondents indicated that quality standards are getting more
stringent in their laboratories, with over 80% finding that their
current workflow requires further optimization.
The top strategies being deployed by lab leaders to more
efficiently move drugs through the pipeline are:
- Buying more sophisticated instruments
that deliver a greater degree of specificity (85%)
- Improving documentation of the sample
chain of custody (70%)
- Employing better-qualified staff
(56%).
“Agilent is dedicated to continually listening to customers to
ensure their success,” said Lon Justice, vice president of sales,
marketing, and customer experience at Agilent. “With this survey,
we enhance our learnings about key pharmaceutical laboratory
challenges, goals, and pain points, which have never before been
quantifiable. With these insights, our teams will be able to
continue to bring customer-focused solutions to market, to improve
the science and economics of the labs we serve.”
The top-line results are being launched at this week’s 67th ASMS
Conference on Mass Spectrometry and Allied Topics, in Atlanta,
Georgia.
“Interestingly, 32% of respondents stated that having easier to
use instruments would improve their workflow,” Justice added. “The
new InfinityLab iQ System, which is being launched at this week’s
ASMS conference, and the recently launched 8860 and 8890 GC systems
are both clear demonstrations of how Agilent is responding to these
needs.”
An associated infographic is available on the Agilent Newsroom.
Country-level results will be released over the coming months.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life
sciences, diagnostics and applied chemical markets. With more than
50 years of insight and innovation, Agilent instruments, software,
services, solutions, and people provide trusted answers to
customers' most challenging questions. The company generated
revenues of $4.91 billion in fiscal 2018 and employs 15,550 people
worldwide. Information about Agilent is available at
www.agilent.com. To receive the latest Agilent news, subscribe to
our Newsroom. Follow Agilent on LinkedIn, Twitter, and
Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190604005384/en/
Victoria Wadsworth-HansenAgilent Technologies+1 408 553
2005+45 2933 6980victoria.wadsworth-hansen@agilent.com
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Feb 2024 to Mar 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Mar 2023 to Mar 2024